comparemela.com

Latest Breaking News On - Altamira therapeutic annual report - Page 1 : comparemela.com

Altamira Therapeutics : Corporate Presentation Winter 2023 -December 20, 2023 at 03:15 am EST

DELIVERING RNA - BEYOND THE LIVER Investor Presentation Winter 2023 Forward-Looking Statements .

Securities exchange commissionSecurities exchangeForward looking statementsSecurities actSecurities exchange actAltamira therapeuticAltamira therapeutic annual reportAltamira therapeutics

Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis

HAMILTON, BERMUDA , Sept. 14, 2023 Fresh data from randomized controlled NASAR clinical trial further demonstrate efficacy and tolerability of Bentrio® nasal spray in treatment of.

Bentrio lsmeansSecurities exchangeSecurities exchange commissionAltamira therapeutics ltdTotal nasal symptom scoresTotal nasal symptom scoreRhinoconjunctivitis qualityLife questionnaireSecurities actSecurities exchange actAltamira therapeuticAltamira therapeutic annual reportAltamira therapeutics

Altamira Therapeutics : Corporate Presentation Autumn 2023 -Today at 02:40 am

IND expected in 2024 Rheumatoid Arthritis - IND expected in 2024 Divesting /.

Securities exchangeSecurities exchange commissionForward looking statementsSecurities actSecurities exchange actAltamira therapeuticAltamira therapeutic annual reportAltamira therapeutics

Altamira Therapeutics Announces Pricing of $5 0 Million Public Offering

Altamira Therapeutics Announces Pricing of $5 0 Million Public Offering
bostonstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonstar.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSecurities exchangeSecurities exchange commissionCompany nasdaqExchange commissionHc wainwright coAltamira therapeutics ltdAltamira therapeuticsSecurities actSecurities exchange actAltamira therapeuticRisk factorAltamira therapeutic annual reportTherapeutics ltd

Altamira Therapeutics Announces Pricing of $5 0 Million Public Offering

Altamira Therapeutics Announces Pricing of $5 0 Million Public Offering
dallassun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallassun.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSecurities exchange commissionAltamira therapeutics ltdHc wainwright coSecurities exchangeExchange commissionCompany nasdaqAltamira therapeuticsSecurities actSecurities exchange actAltamira therapeuticRisk factorAltamira therapeutic annual reportTherapeutics ltd

vimarsana © 2020. All Rights Reserved.